🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2024-518609-17-00
Completed Phase II

The effect of CBD on sleep quality following late evening exercise

2024-518609-17-00 · tracked via the Priya Life Science EU tracker
Sponsor
UZ Leuven
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Physiological processes
Decision date
21/01/2026
Enrollment target
20
Sites
Belgium

Condition studied

healthy individuals

Investigational medicinal product(s)

CannabidiolSoftisan 378

Eligibility

Age group
18-64 years
Sex
Female, Male

Primary endpoint

Changes in sleep efficiency between different sessions

Endpoint detail

Changes in other sleep indices between different sessions, Changes in perceived sleep quality between different sessions, Changes in circulating hormones involved in sleep and stress between different sessions, Changes in plasma catecholamines and serotonin between different sessions, Changes urinary catecholamine and serotonin excretion between different sessions

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2024-518609-17-00 on CTIS ↗ ← All trials in the EU